본문 바로가기
KERD
논문KCI 등재

Response to three years of growth hormone therapy in girls with Turner syndrome

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: Short stature is the most common finding in patients with Turner syndrome. Improving the final adult height in these patients is a challenge both for the patients and physicians. We investigated the clinical response of patients to growth hormone treatment for height improvement over the period of three years. Methods: Review of medical records from 27 patients with Turner syndrome treated with recombinant human growth hormone for more than 3 years was done. Differences in the changes of height standard deviation scores according to karyotype were measured and factors influencing the height changes were analyzed. Results: The response to recombinant human growth hormone was an increase in the height of the subjects to a mean value of 1.1 standard deviation for subjects with Turner syndrome at the end of the 3-year treatment. The height increment in the first year was highest. The height standard deviation score in the third year was negatively correlated with the age at the beginning of the recombinant human growth hormone treatment. Different karyotypes in subjects did not seem to affect the height changes. Conclusion: Early growth hormone administration in subjects with Turner syndrome is helpful to improve height response to the treatment.

Abstract

Purpose: Short stature is the most common finding in patients with Turner syndrome. Improving the final adult height in these patients is a challenge both for the patients and physicians. We investigated the clinical response of patients to growth hormone treatment for height improvement over the period of three years. Methods: Review of medical records from 27 patients with Turner syndrome treated with recombinant human growth hormone for more than 3 years was done. Differences in the changes of height standard deviation scores according to karyotype were measured and factors influencing the height changes were analyzed. Results: The response to recombinant human growth hormone was an increase in the height of the subjects to a mean value of 1.1 standard deviation for subjects with Turner syndrome at the end of the 3-year treatment. The height increment in the first year was highest. The height standard deviation score in the third year was negatively correlated with the age at the beginning of the recombinant human growth hormone treatment. Different karyotypes in subjects did not seem to affect the height changes. Conclusion: Early growth hormone administration in subjects with Turner syndrome is helpful to improve height response to the treatment.

참고문헌 (40)

  1. Nielsen J, "Chromosome abnormalities found among 34,910 newborn children: results from a 13- year incidence study in Arhus, Denmark", Hum Genet, 87, pp.81~83 (1991)
  2. Rochiccioli P, "Study of final height in Turner's syndrome: ethnic and genetic influences", Acta Paediatr, 83, pp.305~308 (1994)
  3. Rongen-Westerlaken C, "Reference values for height, height velocity and weight in Turner's syndrome. Swedish Study Group for GH treatment", Acta Paediatr, 86, pp.937~942 (1997)
  4. Spiliotis BE, "Recombinant human growth hormone in the treatment of Turner syndrome", Ther Clin Risk Manag, 4, pp.1177~1183 (2008)
  5. Rosenfeld RG, "Growth hormone therapy in Turner's syndrome: an update on final height", Acta Paediatr Suppl, 383, pp.3~6 (1992), Genentech National Cooperative Study Group
  6. Saenger P, "Recommendations for the diagnosis and management of Turner syndrome", J Clin Endocrinol Metab, 86, pp.3061~3069 (2001)
  7. Davenport ML, "Approach to the patient with Turner syndrome", J Clin Endocrinol Metab, 95, pp.1487~1495 (2010)
  8. Reiter EO, "Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome", J Clin Endocrinol Metab, 86, pp.1936~1941 (2001)
  9. Wasniewska M, "Early treatment with GH alone in Turner syndrome: prepubertal catch-up growth and waning effect", Eur J Endocrinol, 151, pp.567~572 (2004)
  10. Ranke MB, "Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS", Pediatr Res, 61, pp.105~110 (2007)
  11. Greulich WW, "Radiographic atlas of skeletal development of the hand and wrist" (1959), Stanford University Press
  12. Shin JH, "Spontaneous growth in Korean patients with Turner syndrome", J Korean Soc Pediatr Endocrinol, 3, pp.1~6 (1998)
  13. Ranke MB, "Prediction of longterm response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study", J Clin Endocrinol Metab, 85, pp.4212~4218 (2000)
  14. Quigley CA, "Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height", J Clin Endocrinol Metab, 87, pp.2033~2041 (2002)
  15. Hughes IP, "Growth hormone treatment for Turner syndrome in Australia reveals that younger age and increased dose interact to improve response", Clin Endocrinol (Oxf), 74, pp.473~480 (2011)
  16. Betts PR, "A decade of growth hormone treatment in girls with Turner syndrome in the UK", Arch Dis Child, 80, pp.221~225 (1999), UK KIGS Executive Group
  17. Sas TC, "Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized doseresponse trial", J Clin Endocrinol Metab, 84, pp.4607~4612 (1999)
  18. Amundson E, "Impact of growth hormone therapy on quality of life in adults with Turner syndrome", J Clin Endocrinol Metab, 95, pp.1355~1359 (2010)
  19. Ross JL, "Growth hormone secretory dynamics in Turner syndrome", J Pediatr, 106, pp.202~206 (1985)
  20. Lin TH, "Growth hormone assessment and short-term treatment with growth hormone in Turner syndrome", J Pediatr, 112, pp.919~922 (1988)
  21. Reiter JC, "Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity", Acta Endocrinol (Copenh), 125., pp.38~42 (1991)
  22. Ranke MB, "Growth hormone, somatomedin levels and growth regulation in Turner's syndrome", Acta Endocrinol (Copenh), 116, pp.305~313 (1987)
  23. Wit JM, "Growth hormone secretion in patients with Turner's syndrome as determined by time series analysis", Acta Endocrinol (Copenh), 127, pp.7~12 (1992)
  24. Rao E, "Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome", Nat Genet, 16, pp.54~63 (1997)
  25. Blaschke RJ, "Transcriptional and translational regulation of the Leri-Weill and Turner syndrome homeobox gene SHOX", J Biol Chem, 278, pp.47820~47826 (2003)
  26. Zinn AR, "Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1", Am J Hum Genet, 63, pp.1757~1766 (1998)
  27. Ogata T, "Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients", J Clin Endocrinol Metab, 86, pp.5498~5508 (2001)
  28. Chu CE, "Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner's syndrome", Acta Paediatr, 86, pp.160~164 (1997)
  29. Rosenfeld RG, "Growth hormone therapy of Turner's syndrome: beneficial effect on adult height", J Pediatr, 132, pp.319~324 (1998)
  30. Chernausek SD, "Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height", J Clin Endocrinol Metab, 85, pp.2439~2445 (2000), Genentech, Inc., Collaborative Study Group
  31. Chung SC, "Final adult height in patients with Turner syndrome", J Korean Soc Pediatr Endocrinol, 2, pp.60~69 (1997)
  32. Shin JH, "Growth hormone therapy in girls with Turner syndrome; results of the Korean Turner Study Group", J Korean Soc Pediatr Endocrinol, 3, pp.151~156 (1998)
  33. Cowell CT, "Growth hormone therapy for 3 years: the OZGROW experience", J Paediatr Child Health, 32, pp.86~93 (1996)
  34. Bakker B, "Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children", J Clin Endocrinol Metab, 93, pp.352~357 (2008)
  35. Davenport ML, "Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial", J Clin Endocrinol Metab, 92, pp.3406~3416 (2007)
  36. Linglart A, "Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome", Eur J Endocrinol, 164, pp.891~897 (2011)
  37. Lyon AJ, "Growth curve for girls with Turner syndrome", Arch Dis Child, 60, pp.932~935 (1985)
  38. Even L, "Longitudinal analysis of growth over the first 3 years of life in Turner's syndrome", J Pediatr, 137, pp.460~464 (2000)
  39. Davenport ML, "Growth failure in early life: an important manifestation of Turner syndrome", Horm Res, 57, pp.157~164 (2002)
  40. Bolar K, "Long-term safety of recombinant human growth hormone in Turner syndrome", J Clin Endocrinol Metab, 93, pp.344~351 (2008)

관련 논문AI추천

Response of children with Turner syndrome with different types of karyotype abnormalities to growth hormone treatment김혜순, 유지숙, Choi Jung Eun, Park Mi Jung대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2024 · 제29권 제5호No influence of parental origin of intact X chromosome and/or Y chromosome sequences on three-year height response to growth hormone therapy in Turner syndrome김재현, 김지현, 김화영, 신충호, 양세원, 이경민, 이선희, 이영아, 이혜진, 정혜운대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2014 · 제19권 제3호Growth hormone treatment in non–growth hormonedeficient childrenAnastasia Ibba, Chiara Guzzetti, Luisanna Carta, Sandro Loche대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2014 · 제19권 제1호Effect of growth hormone treatment on children with idiopathic short stature and idiopathic growth hormone deficiency김용대, 임민지, 한헌석대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2017 · 제22권 제2호저신장 소아를 위한 성장호르몬 치료박용훈영남대학교 의과대학 · Journal of Yeungnam Medical Science2005 · 제22권 제1호Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency이정현, 전종근, Chung Woo Yeong, Kim Hyun-Ji, Kim Jeongyun, Kim Ye Jin, Kwak Min Jung, Lee Jeong Eun, Yoo Jae-Ho, Yoon Ju Young대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2022 · 제27권 제1호

이 간행물의 다른 논문 (7건)